Immunoassays Market Research Reports & Industry Analysis
An immunoassay is one of the most effectual analytical tests performed due to its specificity, sensitivity and versatility. To test the concentration of a substance within a solution, immunoassay tests use specific antibodies that will react with antigens in the solution. Monoclonal antibodies provide accurate test results and are the most common antibodies used in immunoassay testing due to their ability to bind to one site of any particular molecule. To get an accurate result, the specific antibody must have a high affinity to the antigen being tested for. The number of antigens and antibodies present in the tested solution is measured. This measurement tells how much of the analyte is located within the sample and how concentrated it is.
One of the most widely used immunoassay applications for the detection of infectious disease is the enzyme-linked immunosorbant assay (ELISA). Because of its high sensitivity, the ELISA was the first screening test widely used for HIV.
Immunoassays are significant tests that perform an array of functions in conventional medicine. While it is used primarily to test for things such as HIV in the body, the test can also be used to discover new ways to test for other diseases and conditions that don’t have a direct scientific diagnostic method.
Immunoassays Industry Research & Market Reports
-
Global Semen Analysis Market - 2023-2030
... called sperm analysis is performed to assess the viability, health, and quality of sperm. It is done by couples unable to conceive naturally and for medical purposes like animal breeding. The analysis is done to ... Read More
-
Hemoglobin A1c (HbA1c) Testing Global Market Opportunities And Strategies To 2034 Including: 1) By Type: Laboratory Based Testing; Point Of Care (PoC) Testing 2) By Product Type: Reagents And Kits; Instruments; Software And Services 3) By Technology: Immunoassays; Chromatography; Enzymatic Assays; Boronate Affinity Chromatography; High Performance Liquid Chromatography 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Settings Covering: Danaher Corporation (Beckman Coulter, Inc.); F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; Abbott Laboratories; Bio-Rad Laboratories, Inc.
... (HbA1c) testing market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies. Understand how the market ... Read More
-
Cell Counting Market by Product (Instruments (Spectrophotometer, Flow Cytometer, Hematology Analyzers, Cell Counters), Consumables (Media, Reagents, Assays, Microplate)), Application, End User (Pharma & Biotech) - Global Forecast to 2029
... to the adoption of fluorescence-based methods, offering enhanced sensitivity and specificity. Furthermore, the expanding focus on drug discovery, stem cell research, and regenerative medicine has amplified the demand for precise cell counting technologies across academic, ... Read More
-
Dermatology Diagnostic Devices Market Report by Product Type (Imaging Devices, Microscopes, Immunoassays, Molecular Diagnostics, and Others), End Use (Hospitals, Diagnostic Labs, and Others), and Region 2025-2033
... 2025-2033. The growing prevalence of skin disorders, increasing demand for non-invasive surgical methods, and rising number of specialty clinics and hospitals represent some of the key factors driving the market. Technological Advancements Propelling Market Growth ... Read More
-
In Vitro Diagnostics (IVD) Quality Control Global Market Report 2025 Including: 1) By Product type: Quality Control Products; Data Management Solutions; Quality Assurance Services 2) By Manufacturer Type: IVD Instrument Manufacturers; Third Party Quality Control Manufacturers 3) By Application: Clinical Chemistry; Hematology; Immunoassay; Molecular Diagnostics; Microbiology; Coagulation Or Hemostasis 4) By End-Users: Hospitals; Clinical Laboratories; Research And Academic Institutes Covering: Bio-Rad Laboratories Inc.; Thermo Fisher Scientific Inc.; LGC Limited.; Abbott Laboratories; Roche Diagnostics AG
... in vitro diagnostics (ivd) quality control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to ... Read More
-
Creatinine Assay Kits
... at a CAGR of 2.2% over the analysis period 2024-2030. Jaffe`s Kinetic Test Kits, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$102.1 Million by the ... Read More
-
Rapid Tests
... CAGR of 5.9% over the analysis period 2024-2030. PCR-based Rapid Tests, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$20.0 Billion by the end of the ... Read More
-
Radioimmunoassays
... 3.2% over the analysis period 2024-2030. Radioimmunoassay Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$458.7 Million by the end of the analysis ... Read More
-
In Vitro Diagnostics
... at a CAGR of 3.4% over the analysis period 2024-2030. IVD Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$86.3 Billion by the ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Forensic Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the ... Read More
-
Hemoglobin A1C (HbA1C) Testing
... 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Ion-Exchange High Performance Liquid Chromatography (HPLC) Technology, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and ... Read More
-
Reporter Gene Assays
... at a CAGR of 6.5% over the analysis period 2024-2030. Luciferase Assays, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$4.6 Billion by the end of ... Read More
-
Cancer / Tumor Profiling
... 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$6.7 Billion by the ... Read More
-
High-Density Multiplexed Diagnostic Assays
... 2030, growing at a CAGR of 14.7% over the analysis period 2024-2030. Diagnostic Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$1.8 Billion by ... Read More
-
Mycotoxin Testing
... CAGR of 5.9% over the analysis period 2024-2030. Spectroscopy- & Chromatography-Based Technology, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.6 Billion by the end of ... Read More
-
Protein Binding Assays
... at a CAGR of 9.4% over the analysis period 2024-2030. Equilibrium Dialysis Technology, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$342.2 Million by the end ... Read More
-
In Vitro Toxicology Testing
... 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.2 Billion by ... Read More
-
Immunofluorescence Assays
... CAGR of 4.4% over the analysis period 2024-2030. Immunofluorescence Assay Reagents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.8 Billion by the end of the ... Read More
-
Cell Proliferation Kits
... at a CAGR of 5.5% over the analysis period 2024-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$394.2 Million by ... Read More
-
C-Reactive Protein Testing
... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Endocrine Testing
... CAGR of 5.0% over the analysis period 2024-2030. Thyroid Stimulating Hormone (TSH) Testing, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.3 Billion by the end ... Read More
-
Automated Liquid Handling Systems
... 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Automated Liquid Handling Workstations, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.6 Billion ... Read More
-
Zika Virus Testing
... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More
-
Immunoprotein Diagnostic Testing
... at a CAGR of 5.2% over the analysis period 2024-2030. Immunoglobulin Diagnostic Testing, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$6.4 Billion by the end ... Read More
-
Infectious Disease Diagnostics
... at a CAGR of 5.5% over the analysis period 2024-2030. Diagnostic Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the ... Read More
Research Assistance
